BioDue Expands with Acquisition of Three Assets from Venture Life

Deal News | May 15, 2025 | Finance Community IT - 3 Private Equity

BioDue Expands with Acquisition of Three Assets from Venture Life

BioDue, a portfolio company of The Riverside Company, has finalized a strategic acquisition of three assets from UK-based Venture Life Group. The acquisition includes Biokosmes, an Italian skincare manufacturer, along with Venture Life Manufacturing AB, a holding company with subsidiaries in Sweden. The deal, valued at 62 million euros, also comprises a package of products and commercial agreements. The transaction, which sees BioDue expand its reach into medical devices and cosmetics, is in line with Riverside's focus on the intersection of healthcare and consumer products. As part of the terms, Venture Life Group will enter into a long-term manufacturing agreement with BioDue. The acquisition has the potential to double BioDue's production capacity and further enrich its portfolio. Advisors including Bird & Bird, Simmons & Simmons, and White & Case assisted in facilitating this transaction.

Sectors

  • Healthcare and Consumer Products
  • Private Equity

Geography

  • Italy – BioDue is an Italian company and a principal operator in the Italian market for food supplements and medical devices.
  • United Kingdom – Venture Life Group, the company selling assets to BioDue, is based in the UK.
  • Sweden – Part of the acquisition involves Swedish operations, expanding BioDue's production and market presence in Northern Europe.

Industry

  • Healthcare and Consumer Products – This sector is relevant as it involves companies operating in healthcare, skincare, and consumer products, which are all part of the acquisition.
  • Private Equity – The Riverside Company, a private equity firm, is significantly involved in funding and strategizing this acquisition.

Financials

  • 62 million euros – The total value of the transaction for BioDue to acquire assets from Venture Life Group.

Participants

NameRoleTypeDescription
The Riverside CompanyPrivate Equity SponsorCompanyA global private equity firm supporting the acquisition and strategic growth of BioDue.
BioDueTarget companyCompanyAn Italian company involved in the acquisition of assets from Venture Life to expand its product offerings.
Venture Life GroupSelling CompanyCompanyA UK-based consumer healthcare company divesting its assets to BioDue.
Bird & BirdLegal AdvisorCompanyLegal firm advising Riverside on the transaction.
Simmons & SimmonsLegal AdvisorCompanyLegal advisor assisting VLG in Italy.
White & CaseFinancial AdvisorCompanyAdvising on finance aspects related to BlackRock's involvement.